BACKGROUND: It has been rarely reported that different inductors are used to induce bone marrow mesenchymal stem cells to differentiate into cardiomyocyte-like cells.
OBJECTIVE: To investigate the effects of 5-azacytidine, angiotensin Ⅱ, bone morphogenetic protein 2, pifithrin-α on induced differentiation of bone marrow mesenchymal stem cells into cardiomyocyte-like cells.
METHODS: Passage 3 rat bone marrow mesenchymal stem cells were divided into five groups: control, 5-azacytidine, angiotensin Ⅱ, bone morphogenetic protein 2, pifithrin-α. Surface antigen expression of bone marrow mesenchymal stem cells was identified by flow cytometry. After 4 weeks of induction, Cx43 and troponin Ⅰ expression was detected by western blot method and calcium transient capability of induced bone marrow mesenchymal stem cells was detected by laser confocal scanning microscopy with flou3/AM.
RESULTS AND CONCLUSION: Cell surface antigen CD29, CD44, CD45 positive rate was 89.1%, 90.4%, 1.9% respectively. Troponin Ⅰ expression appeared in each group and the expression was significantly higher in the pifithrin-α group (P < 0.05), as well as significantly lower in the bone morphogenetic protein 2 group (P < 0.05), compared with the remaining groups. Cx 43 expression appeared in each group, and the expression was significantly lower in the control group (P < 0.05) compared with the remaining groups. In the four experimental groups, Cx43 expression was highest in the pifithrin-α group and lowest in the angiotensin Ⅱ group (P < 0.05). Calcium transient capability determined by fluorescence intensity was arranged as follows: angiotensin Ⅱ group > pifithrin-α group > 5-azacytidine group > bone morphogenetic protein 2 group > control group (P < 0.01). These findings suggest that after induced by 5-azacytidine, angiotensin Ⅱ, bone morphogenetic protein 2, and pifithrin-α, bone marrow mesenchymal stem cells differentiated towards cardiomyocyte-like cells and expressed myocardium-specific protein. Different inductors exert different effects on differentiation of bone marrow mesenchymal stem cells into cardiomyocyte-like cells which occurs because of different pathways.